Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011).
Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011).
复制标题
DOI:
10.3390/v14020334
复制
发表时间:
2022-02-07
期刊:
影响因子:
--
通讯作者:
Kaleebu P
中科院分区:
文献类型:
--
作者:
Balinda SN;Kapaata A;Xu R;Salazar MG;Mezzell AT;Qin Q;Herard K;Dilernia D;Kamali A;Ruzagira E;Kibengo FM;Song H;Ochsenbauer C;Salazar-Gonzalez JF;Gilmour J;Hunter E;Yue L;Kaleebu P
Detailed characterization of transmitted HIV-1 variants in Uganda is fundamentally important to inform vaccine design, yet studies on the transmitted full-length strains of subtype D viruses are limited. Here, we amplified single genomes and characterized viruses, some of which were previously classified as subtype D by sub-genomic pol sequencing that were transmitted in Uganda between December 2006 to June 2011. Analysis of 5′ and 3′ half genome sequences showed 73% (19/26) of infections involved single virus transmissions, whereas 27% (7/26) of infections involved multiple variant transmissions based on predictions of a model of random virus evolution. Subtype analysis of inferred transmitted/founder viruses showed a high transmission rate of inter-subtype recombinants (69%, 20/29) involving mainly A1/D, while pure subtype D variants accounted for one-third of infections (31%, 9/29). Recombination patterns included a predominance of subtype D in the gag/pol region and a highly recombinogenic envelope gene. The signal peptide-C1 region and gp41 transmembrane domain (Tat2/Rev2 flanking region) were hotspots for A1/D recombination events. Analysis of a panel of 14 transmitted/founder molecular clones showed no difference in replication capacity between subtype D viruses (n = 3) and inter-subtype mosaic recombinants (n = 11). However, individuals infected with high replication capacity viruses had a faster CD4 T cell loss. The high transmission rate of unique inter-subtype recombinants is striking and emphasizes the extraordinary challenge for vaccine design and, in particular, for the highly variable and recombinogenic envelope gene, which is targeted by rational designs aimed to elicit broadly neutralizing antibodies.
登录
查看更多内容
影响因子:
14.9
作者:
Dilernia DA;Chien JT;Monaco DC;Brown MP;Ende Z;Deymier MJ;Yue L;Paxinos EE;Allen S;Tirado-Ramos A;Hunter E
通讯作者:
Hunter E
影响因子:
3.7
作者:
Deymier, Martin J.;Claiborne, Daniel T.;Ende, Zachary;Ratner, Hannah K.;Kilembe, William;Allen, Susan;Hunter, Eric
通讯作者:
Hunter, Eric
影响因子:
3.7
作者:
Asmal M;Hellmann I;Liu W;Keele BF;Perelson AS;Bhattacharya T;Gnanakaran S;Daniels M;Haynes BF;Korber BT;Hahn BH;Shaw GM;Letvin NL
通讯作者:
Letvin NL
影响因子:
6.7
作者:
Kijak GH;Sanders-Buell E;Chenine AL;Eller MA;Goonetilleke N;Thomas R;Leviyang S;Harbolick EA;Bose M;Pham P;Oropeza C;Poltavee K;O'Sullivan AM;Billings E;Merbah M;Costanzo MC;Warren JA;Slike B;Li H;Peachman KK;Fischer W;Gao F;Cicala C;Arthos J;Eller LA;O'Connell RJ;Sinei S;Maganga L;Kibuuka H;Nitayaphan S;Rao M;Marovich MA;Krebs SJ;Rolland M;Korber BT;Shaw GM;Michael NL;Robb ML;Tovanabutra S;Kim JH
通讯作者:
Kim JH
DOI:
10.1084/jem.20072457
发表时间:
2008-05-12
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Goepfert PA;Lumm W;Farmer P;Matthews P;Prendergast A;Carlson JM;Derdeyn CA;Tang J;Kaslow RA;Bansal A;Yusim K;Heckerman D;Mulenga J;Allen S;Goulder PJ;Hunter E
通讯作者:
Hunter E